セルソース(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4880/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2021/02/05 | 日証協 | 341,600株 | -2.34% | 28,382株 | -53.23% | 251,845株 | -2.62% | 14,412株 | -67.52% |
2021/01/29 | 日証協 | 349,782株 | -0.39% | 60,682株 | +34.1% | 258,615株 | +2.98% | 44,368株 | +68.69% |
2021/01/22 | 日証協 | 351,168株 | -0.48% | 45,250株 | +25.87% | 251,132株 | -4.7% | 26,301株 | +77.08% |
2021/01/15 | 日証協 | 352,868株 | -1.31% | 35,950株 | -68.53% | 263,531株 | -0.58% | 14,853株 | -63.69% |
2021/01/08 | 日証協 | 357,568株 | +9.36% | 114,218株 | +234.46% | 265,079株 | +9.23% | 40,901株 | +26.62% |
2020/12/30 | 日証協 | 326,968株 | -7.68% | 34,150株 | -84.84% | 242,681株 | -10.92% | 32,301株 | -61.25% |
2020/12/25 | 日証協 | 354,168株 | +17.96% | 225,200株 | +272.85% | 272,445株 | +16.73% | 83,366株 | +154% |
2020/12/18 | 日証協 | 300,250株 | -4.67% | 60,400株 | -51.17% | 233,391株 | -7.82% | 32,821株 | -14.69% |
2020/12/11 | 日証協 | 314,950株 | +0.32% | 123,700株 | +45.19% | 253,185株 | +1.13% | 38,472株 | -22.59% |
2020/12/04 | 日証協 | 313,950株 | +8.24% | 85,200株 | +291.72% | 250,367株 | +6.5% | 49,701株 | +855.05% |
2020/11/27 | 日証協 | 290,050株 | +1.26% | 21,750株 | -31.71% | 235,097株 | -0.54% | 5,204株 | -74.78% |
2020/11/20 | 日証協 | 286,450株 | -5.94% | 31,850株 | -74.16% | 236,365株 | -1.75% | 20,638株 | -69.38% |
2020/11/13 | 日証協 | 304,550株 | +37.99% | 123,250株 | -1.75% | 240,583株 | +20.72% | 67,400株 | -33.79% |
2020/11/06 | 日証協 | 220,700株 | +73.23% | 125,450株 | -7.28% | 199,282株 | +111.26% | 101,802株 | +25.68% |
2020/10/30 | 日証協 | 127,400株 | +70.09% | 135,300株 | +345.07% | 94,329株 | +24.35% | 81,000株 | +212.74% |
2020/10/23 | 日証協 | 74,900株 | +11.46% | 30,400株 | +117.14% | 75,855株 | +24.09% | 25,900株 | +15.46% |
2020/10/16 | 日証協 | 67,200株 | -12.04% | 14,000株 | +2.94% | 61,128株 | -8.93% | 22,432株 | +80.9% |
2020/10/09 | 日証協 | 76,400株 | -7.84% | 13,600株 | -57.5% | 67,122株 | -9.44% | 12,400株 | -25.39% |
2020/10/02 | 日証協 | 82,900株 | +4.8% | 32,000株 | +13.48% | 74,122株 | +12.17% | 16,620株 | -6.27% |
※株式分割は考慮していませんのでご注意ください。
Page Top